Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours

Journal of Cancer Research and Clinical Oncology

Volumn 133, Issue 4, 2007, Pages 253-261

  Moubayed, Noemi ^a   Weichenthal, Michael ^a   Harder, Jürgen ^a   Wandel, Elke ^b   Sticherling, Michael ^b,c   Gläser, Regine ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Actinic keratosis; Basal cell carcinoma; Calcium binding protein; Non melanoma skin cancer; Squamous cell carcinoma

Indexed keywords

COMPLEMENTARY DNA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 8; INVOLUCRIN; MESSENGER RNA; PSORIASIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CELL DIFFERENTIATION; CHILD; CONTROLLED STUDY; EPITHELIUM CELL; EPITHELIUM TUMOR; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; MALE; PRECANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; UPREGULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCIUM-BINDING PROTEINS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CHILD; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERLEUKIN-8; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 33846955106     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-006-0164-y     Document Type: Article

References (27)

1. Algermissen B, Sitzmann J, LeMotte P, Czarnetzki B (1996) Differential expression of CRABP II, psoriasin and cytokeratin 1 mRNA in human skin diseases. Arch Dermatol Res 288:426-430
2. Al-Haddad S, Zhang Z, Leygue E, Snell L, Huang A, Niu Y, Hiller-Hitchcock T, Hole K, Murphy LC, Watson PH (1999) Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol 155:2057-2066
3. Alowami S, Qing G, Emberley E, Snell L, Watson PH (2003) Psoriasin (S100A7) expression is altered during skin tumorigenesis. BMC Dermatol 3:1
4. Barker JN, Jones ML, Mitra RS, Crockett-Torabe E, Fantone JC, Kunkel SL, Warren JS, Dixit VM, Nickoloff BJ (1991) Modulation of keratinocyte-derived interleukin-8 which is chemotactic for neutrophils and T lymphocytes. Am J Pathol 139:869-876
5. Boni R, Schuster C, Nehrhoff B, Burg G (2002) Epidemiology of skin cancer. Neuro Endocrinol Lett 23(Suppl 2):48-51
6. Bornscheuer E, Schröder JM, Christophers E, Sticherling M (1996) Interleukin-8 immunoreactivity in malignant tumours of the skin. Acta Derm Venereol 76:210-213
7. Boukamp P (2005) Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis 26:1657-1667
8. Bustin SA (2000) Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25:169-193
9. Carlsson H, Petersson S, Enerbäck C (2005) Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development. Int J Oncol 27:1473-1481
10. Celis JE, Rasmussen HH, Vorum H, Madsen P, Honore B, Wolf H, Orntoft TF (1996) Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J Urol 155:2105-2112
11. Nuzzo S, Sylva-Steenland RM, Koomen CW, de Rie MA, Das PK, Bos JD, Teunissen MB (2000) Exposure to UVB induces accumulation of LFA-1+ T cells and enhanced expression of the chemokine psoriasin in normal human skin. Photochem Photobiol 72:374-382
12. Eckert RL, Broome AM, Ruse M, Robinson N, Ryan D, Lee K (2004) S100 proteins in the epidermis. J Invest Dermatol 123:23-33
13. Emberley ED, Gietz RD, Campbell JD, HayGlass KT, Murphy LC, Watson PH (2002) RanBPM interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in breast cancer. BMC Cancer 2:28
14. Emberley ED, Niu Y, Leygue E, Tomes L, Gietz RD, Murphy LC, Watson PH (2003) Psoriasin interacts with Jab1 and influences breast cancer progression. Cancer Res 63:1954-1961
15. Enerbäck C, Porter DA, Seth P, Sgroi D, Gaudet J, Weremowicz S, Morton CC, Schnitt S, Pitts RL, Stampl J, Barnhart K, Polyak K (2002) Psoriasin expression in mammary epithelial cells in vitro and in vivo. Cancer Res 62:43-47
16. Gläser R, Harder J, Lange H, Bartels J, Christophers E, Schröder JM (2005) Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 6:57-64
17. Hoffmann HJ, Olsen E, Etzerodt M, Madsen P, Thogersen HC, Kruse T, Celis JE (1994) Psoriasin binds calcium and is upregulated by calcium to levels that resemble those observed in normal skin. J Invest Dermatol 103:370-375
18. Jinquan T, Vorum H, Larsen CG, Madsen P, Rasmussen HH, Gesser B, Etzerodt M, Honore B, Celis JE, Thestrup-Pedersen K (1996) Psoriasin: a novel chemotactic protein. J Invest Dermatol 107:5-10
19. Krop I, Marz A, Carlsson H, Li X, Bloushtain-Qimron N, Hu M, Gelman R, Sabel MS, Schnitt S, Ramaswamy S, Kleer CG, Enerback C, Polyak K (2005) A putative role for psoriasin in breast tumor progression. Cancer Res 65:11326-11334
20. La Placa M, Gibellini D, Bianchi T, Patrizi A (2006) Overexpression of MLH-1 and psoriasin genes in cutaneous angiofibromas from tuberous sclerosis complex patients. J Cutan Pathol 33:608-613
21. Leygue E, Snell L, Hiller T, Dotzlaw H, Hole K, Murphy LC, Watson PH (1996) Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma. Cancer Res 56:4606-4609
22. Madan V, Hoban P, Strange RC, Fryer AA, Lear JT (2006) Genetics and risk factors for basal cell carcinoma. Br J Dermatol 154:5-7
23. Madsen P, Rasmussen HH, Leffers H, Honore B, Dejgaard K, Olsen E, Kiil J, Walbum E, Andersen AH, Basse B, et al (1991) Molecular cloning, occurrence, and expression of a novel partially secreted protein psoriasin that is highly up-regulated in psoriatic skin. J Invest Dermatol 97:701-712
24. Porter D, Lahti-Domenici J, Keshaviah A, Bae YK, Argani P, Marks J, Richardson A, Cooper A, Strausberg R, Riggins GJ, Schnitt S, Gabrielson E, Gelman R, Polyak K (2003) Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res 1:362-375
25. Szepietowski JC, Walker C, McKenna DB, Hunter JA, McKenzie RC (2001) Leukaemia inhibitory factor and interleukin-8 expression in nonmelanoma skin cancers. Clin Exp Dermatol 26:72-78
26. Watt FM (1983) Involucrin and other markers of keratinocyte terminal differentiation. J Invest Dermatol 81:100s-103s
27. Wu YY, Rees JL (2000) Variation in epidermal housekeeping gene expression in different pathological states. Acta Derm Venereol 80:2-3